CYTOKINETICS INC

Nasdaq:CYTK

Pharmaceutical Preparations·SOUTH SAN FRANCISCO, CA

Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.

CEO

Blum Robert I

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	2/26/26	→
10-Q	Q3 2025	9/30/25	11/5/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/6/25	→
10-K	FY 2024	12/31/24	2/27/25	→
10-Q	Q3 2024	9/30/24	11/7/24	→
↓

Earnings Releases (8-K)

15 shown

Filed	Period
2/24/26	Q1 FY2026	→
11/5/25	Q4 FY2025	→
8/7/25	Q3 FY2025	→
5/6/25	Q2 FY2025	→
2/27/25	Q1 FY2025	→
8/8/24	Q3 FY2024	→
↓

News (8-K)

65 shown

Filed	Type	Description
2/17/26	Other	Other Events	→
12/19/25	Other	Other Events	→
12/12/25	Other	Other Events	→
11/14/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
9/22/25	Agreement	Entry into a Material Definitive Agreement	→
9/16/25	Other	Other Events	→
↓

Prospectuses & Registrations

19 shown

Filed	Form	Description
2/26/26	S-8	S-8	→
8/7/25	S-8	S-8	→
4/10/25	ARS	ARS	→
2/27/25	S-3ASR	S-3ASR	→
6/3/24	S-8	S-8	→
5/24/24	424B5	424B5	→
↓

Filing History(1000 filings)

TypeDateAccessionPeriodSize

Mar 10, 2026

0001061983-26-000018PRIMARY DOCUMENT

Mar 9, 2026

4.4 KB

Mar 10, 2026

0001061983-26-000017PRIMARY DOCUMENT

Mar 9, 2026

4.4 KB

Mar 10, 2026

0001061983-26-000016PRIMARY DOCUMENT

Mar 9, 2026

6.0 KB

Mar 5, 2026

0001061983-26-000015PRIMARY DOCUMENT

Mar 5, 2026

13.0 KB

144

Mar 2, 2026

0001950047-26-002009

—

4.8 KB

Mar 2, 2026

0001061983-26-000014PRIMARY DOCUMENT

Mar 2, 2026

4.1 KB

Mar 2, 2026

0001061983-26-000013PRIMARY DOCUMENT

Mar 2, 2026

8.0 KB

S-8

Feb 26, 2026

0001193125-26-077462S-8

—

190.0 KB

10-K

Feb 26, 2026

0001193125-26-07649510-K

Dec 31, 2025

16.4 MB

8-K

Feb 24, 2026

0001193125-26-0670128-K

Feb 24, 2026

431.8 KB

SCHEDULE 13G/A

Feb 17, 2026

0001897612-26-000261

—

7.3 KB

8-K

Feb 17, 2026

0001193125-26-0530498-K

Feb 17, 2026

141.0 KB

Feb 5, 2026

0001061983-26-000012PRIMARY DOCUMENT

Feb 5, 2026

8.2 KB

Feb 2, 2026

0001061983-26-000011PRIMARY DOCUMENT

Feb 2, 2026

8.0 KB

Jan 20, 2026

0001061983-26-000010PRIMARY DOCUMENT

Jan 15, 2026

4.4 KB

Jan 16, 2026

0001061983-26-000008PRIMARY DOCUMENT

Jan 15, 2026

4.3 KB

Jan 16, 2026

0001061983-26-000007PRIMARY DOCUMENT

Jan 15, 2026

4.4 KB

Jan 16, 2026

0001061983-26-000006PRIMARY DOCUMENT

Jan 15, 2026

4.4 KB

Jan 16, 2026

0001061983-26-000005PRIMARY DOCUMENT

Jan 15, 2026

5.1 KB

Jan 16, 2026

0001061983-26-000004PRIMARY DOCUMENT

Jan 15, 2026

4.4 KB

Jan 5, 2026

0001061983-26-000002PRIMARY DOCUMENT

Jan 5, 2026

7.7 KB

Jan 2, 2026

0001061983-26-000001PRIMARY DOCUMENT

Jan 2, 2026

9.1 KB

144

Jan 2, 2026

0001950047-26-000082

—

9.7 KB

Dec 30, 2025

0001061983-25-000057PRIMARY DOCUMENT

Dec 29, 2025

4.2 KB

144

Dec 29, 2025

0001950047-25-010741

—

8.2 KB

25 filings shown

Filed	Form	Description
4/10/25	DEF 14A	DEF 14A	→
3/31/25	PRE 14A	PRE 14A	→
4/8/24	DEF 14A	DEF 14A	→
4/7/23	DEF 14A	DEF 14A	→
3/27/23	PRE 14A	PRE 14A	→
4/8/22	DEF 14A	DEF 14A	→
↓

CYTOKINETICS INC

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1000 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/10/26	4	PRIMARY DOCUMENT	→
3/10/26	4	PRIMARY DOCUMENT	→
3/10/26	4	PRIMARY DOCUMENT	→
3/5/26	4	PRIMARY DOCUMENT	→
3/2/26	4	PRIMARY DOCUMENT	→
3/2/26	4	PRIMARY DOCUMENT	→
↓